<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02335801</url>
  </required_header>
  <id_info>
    <org_study_id>TOSCA0001</org_study_id>
    <nct_id>NCT02335801</nct_id>
  </id_info>
  <brief_title>The TOSCA Registry: Hormonal and Metabolic Deficiencies in Chronic Heart Failure</brief_title>
  <acronym>TOSCA</acronym>
  <official_title>The TOSCA Registry: Epidemiology, Clinical and Prognostic Value of Hormonal and Metabolic Deficiencies in Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine whether the presence of metabolic alteration and
      anabolic deficiencies in patients with chronic heart failure are able to identify a subset of
      patients with poor outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite the effectiveness of the neurohormonal model to explain the progression of heart
      failure and the many insights that it provided for the development of new therapies, there is
      increasing clinical evidence that suggests that our current models fail to completely explain
      the disease progression. Thus, neurohormonal models may be necessary but not sufficient to
      explain all aspects of disease progression in the failing heart. There is evidence suggesting
      that in heart failure there is a metabolic imbalance characterized by the predominance of the
      catabolic status over the anabolic drive.

      Aim of this registry is to determine the prevalence of hormone/metabolic deficiencies in
      heart failure patients and to look for possible association with clinical variables.
      Moreover, enrolled patients will be followed up for a mean of 2,5 years in order to collect
      outcome data including all-cause mortality, cardiovascular mortality, hospitalizations.

      This is a multi-center observational study involving several Italian Department of
      Cardiology, Endocrinology, Internal Medicine
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Months</target_duration>
  <primary_outcome>
    <measure>all-cause mortally</measure>
    <time_frame>every six months (up to 5 years)</time_frame>
    <description>outcome assessed during scheduled visits or phone calls</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular mortality</measure>
    <time_frame>every six months (up to 5 years)</time_frame>
    <description>outcome assessed during scheduled visits or phone calls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalizations</measure>
    <time_frame>every six months (up to 5 years)</time_frame>
    <description>outcome assessed during scheduled visits or phone calls</description>
  </secondary_outcome>
  <other_outcome>
    <measure>reduction in peak oxygen consumption</measure>
    <time_frame>every six months (up to 5 years)</time_frame>
    <description>outcome assessed during scheduled visits</description>
  </other_outcome>
  <other_outcome>
    <measure>left ventricular volumes</measure>
    <time_frame>every six months (up to 5 years)</time_frame>
  </other_outcome>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Chronic Heart Failure</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum for determination of hormonal levels
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with stable chronic heart failure with reduced ejection fraction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of either sex affected by CHF, secondary to ischemic or idiopathic dilated
             cardiomyopathy

          -  left ventricle ejection fraction 40% or less

        Exclusion Criteria:

          -  severe liver disease

          -  serum creatinine levels &gt;2.5 mg/dl

          -  history of active cancer with life expectancy below 1 year

          -  acute coronary syndrome in the previous 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Cittadini</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federico II University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Cittadini, Professor</last_name>
    <phone>+39 081 7464375</phone>
    <email>antonio.cittadini@unina.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michele Arcopinto, MD</last_name>
    <phone>+ 39 3397707531</phone>
    <email>michele.arcopinto83@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>U.O. di Cardiologia 2 IRCCS-Istituto Scientifico di Riabilitazione di Cassano delle Murge</name>
      <address>
        <city>Cassano delle Murge</city>
        <state>Bari</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Passantino, MD</last_name>
      <email>andrea.passantino@fsm.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Santa Maria della Pietà Hospital</name>
      <address>
        <city>Nola</city>
        <state>Napoli</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Caliendo, MD</last_name>
      <email>l.caliendo@alice.it</email>
    </contact>
    <contact_backup>
      <last_name>Luciano Carbone, MD</last_name>
      <email>luciano_carbone@virgilio.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Policlinico di Bari</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Iacoviello, MD</last_name>
      <email>massimo.iacoviello@cardio.uniba.it</email>
    </contact>
    <contact_backup>
      <last_name>Vincenzo Triggiani, MD</last_name>
      <email>v.triggiani@endo.uniba.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Policlinico &quot;Vittorio Emanuele&quot; University of Catania</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ines Monte, MD</last_name>
      <email>inemonte@unict.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Unità Operativa di Malattie Cardiovascolari del Policlinico Mater Domini</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Perticone</last_name>
      <email>perticone@unicz.it</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Belfiore</last_name>
      <email>belfiore@unicz.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UOC di Medicina Interna IRCCS Oasi Maria SS</name>
      <address>
        <city>Enna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Letizia Ragusa, MD</last_name>
      <email>lragusa@oasi.en.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UOC Clinica Medica Dipartimento ad Attività Integrata di Medicina Azienda Ospedaliera-Universitaria S.Anna</name>
      <address>
        <city>Ferrara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Manfredini, MD</last_name>
      <email>roberto.manfredini@unife.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florence</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pietro Amedeo Modesti, MD</last_name>
      <email>pamodesti@unifi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico San Donato Milanese</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Arcopinto, MD</last_name>
      <email>michele.arcopinto83@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Traslational Sciences - Federico II University</name>
      <address>
        <city>Naples</city>
        <zip>80100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Cittadini, MD</last_name>
      <phone>+39 081 7464375</phone>
      <email>antonio.cittadini@unina.it</email>
    </contact>
    <contact_backup>
      <last_name>Michele Arcopinto, MD</last_name>
      <phone>+39 339 7707531</phone>
      <email>michele.arcopinto83@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>AORN V. Monaldi SUN - Centro di diagnosi e cura Cardiomiopatie e Scompenso Cardiaco</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Limongelli, MD</last_name>
      <email>limongelligiuseppe@libero.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Scienze Biomediche Avanzate Università degli studi di Napoli Federico II</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pasquale Perrone-Filardi, MD</last_name>
      <email>pasquale.perronefilardi@unina.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O.S. Endocrinologia Ospedali Riuniti &quot;Villa Sofia - Cervello&quot;</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Graziella Malizia, MD</last_name>
      <email>graziella.malizia@alice.it</email>
    </contact>
    <contact_backup>
      <last_name>Piernicola Garofalo, MD</last_name>
      <email>piernicolagarofalo@alice.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>U.O. di Riabilitazione Cardiologica IRCCS S. Raffaele Pisana</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurizio Volterrani, MD</last_name>
      <email>maurizio.volterrani@sanraffaele.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UOC Endocrinologia e Malattie del Metabolismo Policlinico Universitario Gemelli</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Mancini, MD</last_name>
      <email>mancini.giac@mclink.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O. di Cardiologia e UTIC Ospedale S. Maria Incoronata dell'Olmo</name>
      <address>
        <city>Salerno</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Bossone, MD, PhD</last_name>
      <email>ebossone@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Francesco Ferrara, MD</last_name>
      <email>francesco.ferrara30@tin.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medicina Generale ad Indirizzo Endocrinologico - d.O. Azienda Ospedaliera Universitaria Integrata</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Castello, MD</last_name>
      <email>roberto.castello@ospedaleuniverona.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Cittadini A, Saldamarco L, Marra AM, Arcopinto M, Carlomagno G, Imbriaco M, Del Forno D, Vigorito C, Merola B, Oliviero U, Fazio S, Saccà L. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab. 2009 Sep;94(9):3329-36. doi: 10.1210/jc.2009-0533. Epub 2009 Jul 7.</citation>
    <PMID>19584187</PMID>
  </reference>
  <results_reference>
    <citation>Bossone E, Limongelli G, Malizia G, Ferrara F, Vriz O, Citro R, Marra AM, Arcopinto M, Bobbio E, Sirico D, Caliendo L, Ballotta A, D'Andrea A, Frigiola A, Isgaard J, Saccà L, Antonio C; T.O.S.CA. Investigators. The T.O.S.CA. Project: research, education and care. Monaldi Arch Chest Dis. 2011 Dec;76(4):198-203.</citation>
    <PMID>22567736</PMID>
  </results_reference>
  <results_reference>
    <citation>Arcopinto M, Isgaard J, Marra AM, Formisano P, Bossone E, Vriz O, Vigorito C, Saccà L, Douglas PS, Cittadini A. IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry. Int J Cardiol. 2014 Oct 20;176(3):1006-8. doi: 10.1016/j.ijcard.2014.07.003. Epub 2014 Jul 11.</citation>
    <PMID>25037691</PMID>
  </results_reference>
  <results_reference>
    <citation>Cittadini A, Marra AM, Arcopinto M, Bobbio E, Salzano A, Sirico D, Napoli R, Colao A, Longobardi S, Baliga RR, Bossone E, Saccà L. Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. JACC Heart Fail. 2013 Aug;1(4):325-330. doi: 10.1016/j.jchf.2013.04.003. Epub 2013 Aug 5.</citation>
    <PMID>24621936</PMID>
  </results_reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>January 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2015</study_first_posted>
  <last_update_submitted>January 9, 2015</last_update_submitted>
  <last_update_submitted_qc>January 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Antonio Cittadini</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>growth hormone</keyword>
  <keyword>testosterone</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>thyroid hormones</keyword>
  <keyword>survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

